Macababayao, Ethan G.
HRN: 23-82-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/10/2023
10/17/2023
IV
100mg
Q6hours
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes